Bacterial Biomarkers of the Oropharyngeal and Oral Cavity during SARS-CoV-2 Infection

Author:

Bourumeau William12,Tremblay Karine34ORCID,Jourdan Guillaume2,Girard Catherine12,Laprise Catherine12ORCID

Affiliation:

1. Département des Sciences Fondamentales, Université du Québec à Chicoutimi, Saguenay, QC G7H 2B1, Canada

2. Centre Intersectoriel en Santé Durable, Université du Québec à Chicoutimi, Saguenay, QC G7H 2B1, Canada

3. Pharmacology-Physiology Department, Université de Sherbrooke, Saguenay, QC J1K 2R1, Canada

4. Research Centre of Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean (CIUSSS-SLSJ), Saguenay, QC G7H 7K9, Canada

Abstract

(1) Background: Individuals with COVID-19 display different forms of disease severity and the upper respiratory tract microbiome has been suggested to play a crucial role in the development of its symptoms. (2) Methods: The present study analyzed the microbial profiles of the oral cavity and oropharynx of 182 COVID-19 patients compared to 75 unaffected individuals. The samples were obtained from gargle screening samples. 16S rRNA amplicon sequencing was applied to analyze the samples. (3) Results: The present study shows that SARS-CoV-2 infection induced significant differences in bacterial community assemblages, with Prevotella and Veillonella as biomarkers for positive-tested people and Streptococcus and Actinomyces for negative-tested people. It also suggests a state of dysbiosis on the part of the infected individuals due to significant differences in the bacterial community in favor of a microbiome richer in opportunistic pathogens. (4) Conclusions: SARS-CoV-2 infection induces dysbiosis in the upper respiratory tract. The identification of these opportunistic pathogenic biomarkers could be a new screening and prevention tool for people with prior dysbiosis.

Funder

Fonds de recherche du Québec—Santé

Génome Québec

Public Health Agency of Canada

ministère de la Santé et des Services sociaux

Canada Foundation for Innovation

Publisher

MDPI AG

Subject

Virology,Microbiology (medical),Microbiology

Reference89 articles.

1. World Health Organization (2022). World Health Organization Coronavirus Disease (COVID-19) Pandemic 2022, World Health Organization.

2. World Health Organization (2022). World Health Organization WHO Coronavirus (COVID-19) Dashboard 2022, World Health Organization.

3. Understanding of COVID-19 Based on Current Evidence;Sun;J. Med. Virol.,2020

4. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis;Perelman;Sci. Rep.,2021

5. Emerging Treatment Strategies for COVID-19 Infection;Gavriatopoulou;Clin. Exp. Med.,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3